Zulvac BTV


Bluetongue virus vaccine (inactivated) (multistrain: 1 strain out of a set of 3)

This medicine is authorised for use in the European Union.


Zulvac BTV is a veterinary vaccine used in sheep and cattle to protect them against bluetongue disease, an infection caused by the bluetongue virus, which is transmitted by midges. 

The vaccine contains inactivated (killed) bluetongue virus. When used in sheep or cattle the vaccine contains one of the following three vaccine strains: BTV serotype 1, BTV serotype 4 and BTV serotype 8. The serotype to be used in the vaccine is selected before manufacture depending on which type is circulating and causing disease at the time. 

The vaccine can prevent the presence of serotypes 1 or 8 and reduce levels of serotype 4 in the blood in sheep, and prevent the presence of serotypes 1, 4 or 8 in the blood in cattle.

This EPAR was last updated on 01/09/2021

Authorisation details

Product details
Zulvac BTV
Agency product number
Active substance
One of the following inactivated bluetongue virus strains:Inactivated bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02Inactivated bluetongue virus, serotype 4, strain SPA-1/2004
International non-proprietary name (INN) or common name
Bluetongue virus vaccine (inactivated) (multistrain: 1 strain out of a set of 3)
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve

Product information

20/05/2021 Zulvac BTV - EMEA/V/C/004185 - II/0004

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Immunologicals
  • Immunologicals for bovidae
  • Inactivated viral vaccines
  • bluetongue virus

Therapeutic indication

Active immunisation of sheep from 6 weeks of age for the prevention of viraemia caused by bluetongue virus, serotypes 1 and 8, and for the reduction of viraemia caused by bluetongue virus, serotype 4 and active immunisation of cattle from 12 weeks of age for the prevention of viraemia caused by bluetongue virus, serotypes 1 and 8.

Assessment history

Related content

How useful was this page?

Add your rating
1 rating